Patient Monitoring Markets

  • October 2009
  • -
  • TriMark Publications
  • -
  • 300 pages

Patient monitoring is vital to care in operating rooms, emergency rooms, intensive care units and critical care units. It has proven invaluable for respiratory therapy, recovery rooms, outpatient care, transport, radiology, catheterization laboratories and gastroenterology departments, as well as for ambulatory, home and sleep screening applications. Patient monitoring can reduce the risk of infection and other complications, and it can assist in providing for patient comfort. Moreover, patient monitoring products measure, display and document physiological information obtained at regular intervals over time from sensors attached to the patient or other input devices. The qualifier “at regular intervals over time” is used to distinguish patient monitoring devices from diagnostic kits and devices, which are typically used once or a few times to diagnose a patient’s condition and/or plan a course of therapy.

Measured parameters include electrocardiogram (ECG), invasive and noninvasive blood pressure, pulse rate, pulse oximetry, body temperature, respiration rate, end-tidal CO2 and other specialized parameters. Products vary from specialized single-parameter instruments to monitors with the ability to measure multiple parameters and interface with other instruments. This TriMark Publications report assesses the patient monitoring device market drivers and bottlenecks from the perspective of medical and manufacturer communities; discusses the potential benefits of the patient monitoring device market for various sectors of the medical community; establishes the current total market size and future growth of the patient monitoring device market and analyzes the current size and growth of various segments; provides current and forecasted market shares by the company; provides strategic recommendations for near-term business opportunities and assesses current commercial uses of the patient monitoring market.

Table Of Contents

TABLE OF CONTENTS

1. Introduction 11
1.1 Objectives of this Report 11
1.2 Scope of this Report 11
1.3 Methodology 12
1.4 Executive Summary 13
1.4.1 The U.S. Medical Device Market 13
1.4.2 Supply and Demand Fundamentals 13
1.4.3 Sector Convergence 14
1.4.4 Future Forecast 14
1.5 The Leader in Patient Monitors 22
1.6 U.S. Market for Patient Monitors 22
1.7 Indian Market for Patient Monitors 22
1.8 South East Asia's Patient Monitoring Market 23

2. Market for Diabetes Monitoring 25
2.1 Market for Blood Glucose Meters and Test Strips 27
2.2 U.S. Market for Diabetes Care 28
2.3 Self Monitoring Blood Glucose (SMBG) Device Market in Asia-Pacific 29
2.4 Reviews of the Latest Glucose Meters 30
2.4.1 Abbott Glucose Meters 30
2.4.2 Glucose Meters from Bayer Healthcare 35
2.4.3 Glucose Meters from LifeScan 40
2.4.4 Glucose Meters from Roche 46
2.4.5 Glucose Meters from Home Diagnostics 49

3. Sleep Market 57
3.1 Sleep-Disordered Breathing (SDB) and Sleep Apnea 57
3.2 Existing Therapies for Sleep Apnea 58
3.3 Market for Sleep Apnea 58
3.4 ResMed Corporation's Sleep Business 59
3.4.1 Airflow Generators 59
3.4.2 ResMed's Mask Systems and Diagnostic Products 61
3.4.3 ResMed's Competitors 64
3.5 Pictorial Profile of a Few Sleep Products from ResMed 64
3.6 Sleep Products from Philips Respironics, Inc. 70
3.7 The Awakening of the Sleep Market 73
3.8 New Investment in Sleep Apnea by GE and Intel 74

4. Pulse Oximetry 75
4.1 Pulse Oximeters from Nellcor 77
4.2 Pulse Oximeters from GE Healthcare 79
4.3 Pulse Oximeters from Criticare Systems, Inc. 80
4.4 Pulse Oximeters from Masimo Corporation 81
4.5 Pulse Oximeters from Nihon Kohden 83
4.6 Pulse Oximeters from Nonin Medical, Inc. 84
4.7 An Estimation of Pulse Oximetry Gap 85

5. Capnography Market 86
5.1 New Trends in Capnography 87
5.2 European Market for Critical Care Blood Gas Monitoring 89
5.3 Oridion and Capnography 89
5.4 Philips Respironics and Capnography 91
5.5 Smith Medical and Capnography 92
5.6 Nonin Medical and Capnography 93

6. Anesthesia Monitors 94
6.1 European Anesthesia Equipment Market 94
6.2 The Sluggish Western European Market 95
6.3 Sustained Growth in Eastern European Market 95
6.4 Price Sensitivity 95
6.5 Fierce Competition 95
6.6 Fast Growth for Depth of Anesthesia Monitors 96
6.7 Demands for Clinical Application Suites 96
6.8 Hospital IT Aids Market Penetration of AIMS 96
6.9 Future of Anesthesia Equipment Market in the E.U. 96
6.10 Anesthesia Monitors from Drager 97
6.11 Anesthesia Monitors from GE Healthcare 99
6.12 Anesthesia Monitors from Aspect Medical Systems 101
6.13 Anesthesia Monitors from Mindray 102

7. Fetal Monitors 104
7.1 Fetal Monitors from Analogic Corporation 105
7.2 Fetal Monitors from GE Healthcare 105
7.3 Fetal Monitor from Philips Healthcare 107
7.4 Fetal Monitor from Cardinal Health 108
7.5 Fetal Monitor from Nonin Medical 108
7.6 Fetal Monitor from Spacelab Healthcare 109

8. Global Cardiovascular Devices Market 110
8.1 Cardiovascular Monitoring 110
8.1.1 Global Market for Ultrasound Devices 110
8.1.2 Cardiovascular Diseases in the U.S. 111
8.1.3 Market for Electrophysiology Devices in the U.S. 112
8.1.4 Cardiovascular Diseases in Europe 113
8.1.5 Cardiovascular Diseases in India 114
8.2 Cardiology Equipment Market in India 114
8.3 Cardiovascular Monitors from Biosense Webster (Johnson and Johnson) 116
8.4 Cardiovascular Monitors from Boston Scientific 117
8.5 Cardiovascular Monitor from Pulsion Medical Systems 117
8.6 Cardiovascular products from GE Healthcare 118

9. Market for External Defibrillators 120
9.1 Defibrillation 120
9.2 Performance of Defibrillation 120
9.3 Challenges Related to Defibrillation 120
9.4 Types of Defibrillators 121
9.5 Defibrillators from Cardiac Science Corporation 122
9.6 Defibrillators from Physio-Control, Inc. 124

10. Blood Pressure Monitors 127
10.1 AandD Medical/Life Source 127
10.2 Omron Healthcare Co., Ltd. 132
10.3 Japan Precision Instruments, Inc. 132
10.4 Mabis Healthcare Duro-Med Industries (DMI) 135
10.5 Medisana AG 136
10.6 American Diagnostic Corporation 137

11. Holter Monitors 138
11.1 Holter Monitors from Braemar, Inc. 138
11.2 Holter Monitors from Fukuda Denshi 140
11.3 Holter Monitor from Mortara Instrument 141
11.4 Holter Monitor from Philips Healthcare 141
11.5 Holter Monitor from Spacelab Healthcare 142
11.6 Holter Monitor from Schiller AG 142

12. Market for Temperature Monitoring 143

13. Telehealth Market 144
13.1 Intel and GE in Telehealth 145
13.1.1 Usage of Remote Patient Monitoring in U.S. Healthcare Organizations in
2009 146
13.2 Philips Healthcare 147
13.3 Telehealth and Troubled Pregnancies 148
13.4 Telehealth Devices from Tunstall 148

14. High Acuity Areas Monitoring Systems 151
14.1 Patient Monitoring Systems in the High Acuity Area 151
14.2 Advantages 151
14.3 Market Scene 152
14.4 Technology Trends 153
14.5 Key Players 153
14.6 Future of High Acuity Patient Monitors 154
14.7 Product Profiles from Selected Companies 154

15. Global Home Healthcare Market 171
15.1 Home Healthcare Market in the U.S. 171
15.2 Wireless Monitoring in Home Healthcare 173

16. Profiles of Top 30 Medical Device Companies 177
16.1 Johnson and Johnson 177
16.1.1 Johnson and Johnson's Consumer Healthcare Business 177
16.1.2 Johnson and Johnson's Medical Devices and Diagnostics Business 177
16.1.3 Johnson and Johnson's Pharmaceutical Business 178
16.1.4 Research and Development 178
16.2 GE Healthcare 179
16.2.1 GE Healthcare's Surgery Business 179
16.2.2 GE Healthcare's Healthcare Systems Business 179
16.2.3 GE Healthcare's Life Sciences Business 180
16.2.4 GE Healthcare's Medical Diagnostics Business 180
16.2.5 GE Healthcare's Healthcare IT Business 180
16.3 Siemens Healthcare 180
16.4 Medtronic 183
16.4.1 Medtronic's Cardiac Rhythm Disease Management (CRDM) 183
16.4.2 Medtronic's Spinal Products 184
16.4.3 Medtronic's Cardiovascular Products 184
16.4.4 Medtronic's Neuromodulation Products 185
16.4.5 Medtronic's Diabetes Products 185
16.4.6 Medtronic's Surgical Technologies Products 185
16.4.7 Medtronic's Performance in the U.S. and Non-U.S. markets 186
16.5 Cardinal Health 187
16.5.1 Cardinal's Healthcare Supply Chain Services Business 187
16.5.2 Cardinal's Clinical and Medical Products Business 188
16.6 Baxter International 189
16.6.1 Baxter's Bioscience Business 189
16.6.2 Baxter's Medication Delivery Business 189
16.6.3 Baxter's Renal Business 190
16.6.4 Baxter's Global Performance 190
16.7 Philips Healthcare 191
16.7.1 Philips' Cardiology Solutions 192
16.7.2 Philips' Oncology Solutions 192
16.7.3 Philips' Women's Health Solutions 192
16.7.4 Philips' Healthcare Performance 192
16.8 Boston Scientific 193
16.9 Covidien 197
16.10 Becton Dickinson and Company 199
16.11 Abbot Laboratories 202
16.12 Stryker 205
16.12.1 Hip Implant Systems 207
16.12.2 Knee Implant Systems 207
16.12.3 Trauma Implant Systems 207
16.12.4 Spinal Implant Systems 207
16.12.5 Craniomaxillofacial Implant Systems 207
16.12.6 Surgical Equipment and Surgical Navigation Systems 208
16.12.7 Endoscopic, Communications and Digital Imaging Systems 208
16.12.8 Patient Handling and Emergency Medical Equipment 208
16.13 B. Braun 208
16.14 3M Healthcare 212
16.15 Zimmer Holdings 213
16.16 St. Jude Medical 215
16.16.1 Atrial Fibrillation at St. Jude 216
16.16.2 Connectivity at St. Jude 216
16.16.3 Neuromodulation at St. Jude 216
16.17 Hospira, Inc. 219
16.17.1 Hospira's Devices 219
16.18 Smith and Nephew 221
16.18.1 Smith and Nephew's Orthopedics 222
16.18.2 Smith and Nephew's Endoscopy 222
16.18.3 Smith and Nephew's Advanced Wound Management 222
16.18.4 Smith and Nephew's RandD 222
16.19 Danaher 224
16.19.1 Danaher's Medical Technologies 224
16.20 Synthes 226
16.21 Beckman Coulter, Inc. 227
16.22 Olympus Medical Systems 229
16.23 Fresenius Medical Care 231
16.24 Alcon 234
16.25 Terumo Cardiovascular Systems 238
16.25.1 Terumo's General Hospital Products Segment 238
16.25.2 Terumo's Cardiac and Vascular Products Segment 239
16.25.3 Terumo's Home Healthcare Products 239
16.25.4 Terumo's Performance in Geographic Segments 240
16.25.5 Terumo's RandD Programs 241
16.26 C.R. Bard, Inc. 242
16.26.1 Bard's Vascular Products 242
16.26.2 Bard's Urology Products 243
16.26.3 Bard's Oncology Products 243
16.26.4 Bard's Surgical Specialties 244
16.27 Oridion Medical 245
16.27.1 Oridion's Leadership in Capnography 245
16.27.2 Smart Capnography 246
16.27.3 Oridion's Performance 247
16.28 DENTSPLY International, Inc. 248
16.28.1 DENTSPLY's Products 249
16.29 Drager Medical AG and Co. 250
16.30 Varian Medical Systems, Inc. 252
16.30.1 Varian's Oncology Systems 252
16.30.2 Varian's X-ray Products 253
16.30.3 Varian's RandD 254

17. The Invincible Medical Device Industry 256
17.1 Baby Boomers and Incubating Innovations 256
17.2 The Medical Device Industry in 2009 256
17.3 Global Outlook for Medical Devices 257
17.4 Outlook for Medical Devices in India 259
17.4.1 Interventional Cardiology Market in India 261
17.4.2 Molecular Diagnostics Market in India 262
17.4.3 Penetration of Cardiology Informatics in India 263
17.5 Outlook for Medical Devices in Russia 264
17.6 Outlook for Medical Devices in China 265
17.6.1 Penetration of Radiology Informatics in China 266
17.6.2 In Vitro Diagnostics Market in China 266
17.6.3 Impact of Recent Regulations in China 268
17.6.4 Demand for High-end Products in China 268
17.6.5 Forming Partnership with Chinese Companies 270
17.7 South East Asia's X-ray Market 270
17.8 South East Asia's Ultrasound Market 271
17.9 Outlook for Medical Devices in Malaysia 273
17.10 Outlook for Medical Devices in Indonesia 274
17.10.1 Diagnostic Imaging Market in Indonesia 274
17.11 Outlook for Medical Devices in Singapore 275
17.12 Outlook for Medical Devices in Vietnam 276
17.13 Outlook for Medical Devices in Denmark 276
17.14 Outlook for Medical Devices in the U.K. 277

Appendix 1: The Global Medical Device Market 278
Appendix 1.1: Medical Device Market: U.S. 278
Appendix 1.2: Medical Device Market: France 279
Appendix 1.3: Medical Device Market: Turkey 280
Appendix 1.4: Medical Device Market: Romania 281
Appendix 2: Merger and Acquisition (MandA) in Medical Device Sector 283
Appendix 3: The Attractive Market for Investment 284
Appendix 3.1: Domination of Orthopedics 284
Appendix 3.2: Focus on Ophthalmic 284
Appendix 3.3: Patient Monitoring Portfolios 285
Appendix 3.4: Biosurgery and Wound care 285
Appendix 3.5: Cardiology Sector with a Healthy Heartbeat 286
Appendix 3.6: Deals in Diagnostics and Analytics 286
Appendix 3.7: Activities among Components Companies 287
Appendix 3.8: Future MandA Activity 287
Appendix 4: MDEA Award Winners and Patient Monitoring Products, 2008 and 2009
289
Appendix 5: Medical Equipment Market Trends in 2009 295
Appendix 5.1: Stellar Growth for Healthcare Information Technology 295
Appendix 5.2: Home Healthcare Equipment Market Poised for a Big Return 295
Appendix 5.3: Ongoing Trend towards Medical Tourism 296
Appendix 5.4: Medical Equipment Manufacturers Remain Stable Defying Recession
297
Appendix 5.5: Direct To Consumer Advertising Increases 297
Appendix 5.6: Healthcare Information Technology to Gain Attention in Emerging
Economies 298
Appendix 5.7: Drug Eluting Stents on a Comeback Trail in the U.S. 298
Appendix 5.8: Hip Resurfacing Market to Get a Boost from Young Adults and
Middle-aged Patients 298
Appendix 5.9: Cash Rich and Innovative Companies to Thrive in the Present
Economic Scenario 298
Appendix 5.10: Products for Women's Health, Minimally Invasive Surgery and Home
Healthcare to Gain 298
Appendix 5.11: High Value and Low Value of Deals will be a Norm in MandA 299


INDEX OF FIGURES

Figure 1.1: Global Market for Patient Monitors, 2008-2015 14
Figure 1.2: U.S. Market for Patient Monitors, 2008-2015 15
Figure 1.3: Global Market Share for Patient Monitors by Company, 2007 16
Figure 1.4: Global Share of Patient Monitoring Market by Philips, 2007 16
Figure 1.5: Philips' Global Market Share in Patient Monitors, 2003-2007 17
Figure 1.6: GE's Global Market Share in Patient Monitors, 2003-2007 18
Figure 1.7: Drager's Global Market Share in Patient Monitors, 2003-2007 19
Figure 1.8: Mindray's Global Market Share in Patient Monitors, 2003-2007 20
Figure 1.9: Nihon Kohden's Global Market Share in Patient Monitors, 2003-2007 21
Figure 1.10: Nihon Kohden's Market for Patient Monitors, 2008 21
Figure 1.11: South East Asia's Patient Monitor Market, 2007 24
Figure 2.1: The Global Diabetes Care Devices Market, 2008-2015 26
Figure 2.2: Prevalence of Diabetes in the Top Three Diabetic Countries, 2007 and
2025 27
Figure 2.3: Total Economic Cost of Diabetes in the U.S., 2007 28
Figure 2.4: Asia-Pacific SMBG Competitive Market Share, 2007 29
Figure 2.5: Chinese SMBG Competitive Market Share, 2007 30
Figure 2.6: Bayer's Market for Diabetes Care Segment, 2006-2008 35
Figure 2.7: Johnson and Johnson's Market in Diabetes Care, 2008 40
Figure 2.8: Roche's Market in Diabetes Care Segment, 2008 46
Figure 2.9: Home Diagnostics' Market for Glucose Meters and Accessories,
2005-2008 49
Figure 3.1: Global Sleep Apnea Management Market, 2008-2012 59
Figure 3.2: ResMeds's Market for CPAP and VPAP Flow Generators, 2006-2008 59
Figure 3.3: ResMed's Market for Masks and Accessories, 2006-2008 61
Figure 3.4: ResMed's Market for its Sleep Products in the Americas, 2006-2008 63
Figure 3.5: ResMed's Market for its Sleep Products in Europe, 2006-2008 63
Figure 3.6: ResMed's Market in Asia-Pacific and Rest of the World, 2006-2008 64
Figure 4.1: U.S. Pulse Oximetry Market Share by Company, 2008 75
Figure 4.2: Market Growth for U.S. Pulse Oximetry, 2008-2013 76
Figure 4.3: Market for Pulse Oximeters in the E.U., 2008-2015 77
Figure 4.4: Nellcor's (Covidien) Market for Oximetry and Monitoring Products,
2006-2008 77
Figure 4.5: Masimo SET Installed Base, 2004-2008 81
Figure 5.1: E.U. Market for Critical Care Blood Gas Monitoring Products,
2008-2013 89
Figure 5.2: Oridion's Capnography Market, 2004-2008 90
Figure 6.1: Global Anesthesia and Respiratory Devices Market, 2008-2015 94
Figure 6.2: Aspect's Worldwide Total Installed Bases of Monitors and Modules,
2004-2008 101
Figure 6.3: Aspect's Sensor Shipment, 2004-2008 102
Figure 8.1: Global Market for Cardiovascular Devices, 2008-2012 110
Figure 8.2: Global Market for Ultrasound Devices, 2008-2015 111
Figure 8.3: Direct and Indirect Costs of Heart Diseases in the U.S., 2009 112
Figure 8.4: U.S. Electrophysiology Device Market in the U.S., 2008-2015 112
Figure 8.5: European Market for Electrocardiography Products, 2008 113
Figure 8.6: Mortality Rate for CVD, 2007 114
Figure 8.7: Indian ECG Equipment Market by Unit, 2008 115
Figure 8.8: Indian ECG Equipment Market by Value, 2008 115
Figure 8.9: Boston's Cardiology Market, 2008 117
Figure 8.10: Pulsion's Dominance in Intensive Care Unit in Comparison to
Competitors, 2008 118
Figure 9.1: Growth of Manual External Defibrillators, 2008-2012 123
Figure 9.2: Cardiac Science's Market for Defibrillation Products, 2006-2008 124
Figure 13.1: Growth of Telehealth, 2010-2015 144
Figure 13.2: Telehealth Market, 2008-2012 145
Figure 13.3: Growth of Telehealth as Predicted by Intel and GE, 2008-2012 146
Figure 13.4: Remote Patient Monitoring in the U.S. Healthcare Organizations,
2009 146
Figure 14.1: Market Share of Multiparameter Monitoring Equipments by Company,
2008 153
Figure 14.2: Market Share Split among the Key Players in High Acuity Area
Patient Monitors, 2008 154
Figure 15.1: Global Home Healthcare Market, 2008-2012 171
Figure 15.2: U.S. Market for Home Healthcare Products, 2008-2012 172
Figure 15.3: Patients Diagnosed with Common Welfare Diseases in Europe and the
U.S., 2008 174
Figure 15.4: Global Blood Pressure Monitoring Market, 2008-2012 174
Figure 15.5: Global Blood Glucose Monitoring Market, 2008-2012 175
Figure 15.6: Global Lipid Monitoring Market, 2008-2012 175
Figure 16.1: Johnson and Johnson's Consumer Segment Performance, 2008 177
Figure 16.2: Johnson and Johnson's Medical Devices and Diagnostics Performance,
2008 178
Figure 16.3: Johnson and Johnson's Pharmaceutical Business Performance, 2008 178
Figure 16.4: Johnson and Johnson's RandD Expenditure, 2006-2008 179
Figure 16.5: GE Healthcare's Performance, 2004-2008 180
Figure 16.6: Siemens' Business Performance in Healthcare Segment by Geography,
2008 181
Figure 16.7: Siemens' Business Performance in Healthcare Sector by Segment, 2008
182
Figure 16.8: Medtronic's Cardiac Rhythm Disease Management Performance, 2008 184
Figure 16.9: Medtronic's Spine Products Performance, 2008 184
Figure 16.10: Medtronic's Cardiovascular Products Performance, 2008 185
Figure 16.11: Medtronic's Surgical Technologies Products Performance, 2008 186
Figure 16.12: Medtronic's U.S. and Non-U.S. Performance, 2008 186
Figure 16.13: Cardinal's Overall Performance, 2006-2008 187
Figure 16.14: Cardinal's Healthcare Supply Chain Services Performance, 2006-2008
188
Figure 16.15: Cardinal's Clinical and Medical Products Performance, 2007 and
2008 188
Figure 16.16: Baxter's Bioscience Business Performance, 2008 189
Figure 16.17: Baxter's Medication Delivery Business Performance, 2008 190
Figure 16.18: Baxter's Renal Business Performance, 2008 190
Figure 16.19: Baxter's Global Performance, 2006-2008 191
Figure 16.20: Philips' Healthcare Performance, 2006-2008 193
Figure 16.21: Philips Healthcare Performance by Geography, 2008 193
Figure 16.22: Boston's Global Performance, 2004-2008 194
Figure 16.23: Boston's Performance in Cardiac Rhythm Management, 2007 and 2008
194
Figure 16.24: Boston's Performance in Coronary Stent Systems, 2007 and 2008 195
Figure 16.25: Boston's Performance in Endosurgery, 2007 and 2008 196
Figure 16.26: Boston's Global Performance by Geography, 2006-2008 196
Figure 16.27: Covidien's Global Performance, 2004-2008 197
Figure 16.28: Covidien's RandD Expenditure, 2004-2008 198
Figure 16.29: Covidien's Performance by Geographical Region, 2008 198
Figure 16.30: Covidien's Performance in Medical Devices by Groups of Products,
2008 199
Figure 16.31: BD's Global Performance, 2005-2008 200
Figure 16.32: BD's Medical Segment: Performance by Sub-Segment, 2008 200
Figure 16.33: BD's Diagnostic Segment: Performance, 2007 and 2008 201
Figure 16.34: BD's Biosciences Segment: Performance, 2007 and 2008 201
Figure 16.35: BD's U.S. and Non-U.S. Performance, 2008 202
Figure 16.36: Abbott's Global Performance, 2004-2008 203
Figure 16.37: Abbott's Performance: Vascular Segment, 2006-2008 203
Figure 16.38: Abbott's Performance: Diagnostics Segment, 2006-2008 204
Figure 16.39: Abbott's Performance: Pharmaceutical Segment, 2006-2008 204
Figure 16.40: Abbott's Performance: Nutritional Segment, 2006-2008 205
Figure 16.41: Abbott's RandD Expenditure, 2006-2008 205
Figure 16.42: Stryker's Global Performance, 2006-2008 206
Figure 16.43: Stryker's RandD Expenditure, 2006-2008 207
Figure 16.44: B. Braun's Group Performance, 2006-2008 209
Figure 16.45: B. Braun's Performance: Hospital Care Division, 2006-2008 209
Figure 16.46: B. Braun's Performance: Aesculap Division, 2006-2008 210
Figure 16.47: B. Braun's Performance: OPM Division, 2006-2008 210
Figure 16.48: B. Braun's Performance: Avitum Division, 2006-2008 211
Figure 16.49: B. Braun's Employees by Region, 2008 212
Figure 16.50: 3M Healthcare: Global Performance, 2006-2008 213
Figure 16.51: Zimmer's Global Performance, 2006-2008 214
Figure 16.52: Zimmer's Performance by Geographic Segment, 2008 214
Figure 16.53: Zimmer's RandD Expenditure, 2006-2008 215
Figure 16.54: St. Jude's Global Performance, 2006-2008 215
Figure 16.55: St. Jude's Performance in Cardiac Rhythm Management, 2008 217
Figure 16.56: St. Jude's Performance in its Cardiovascular Segment, 2008 217
Figure 16.57: St. Jude's Performance in Atrial Fibrillation Products, 2006-2008
218
Figure 16.58: St. Jude's Performance in Neuromodulation Products, 2006-2008 218
Figure 16.59: Hospira's Global Performance, 2004-2008 219
Figure 16.60: Hospira's Performance in the Americas, 2008 220
Figure 16.61: Hospira's Performance in EMEA Region, 2008 220
Figure 16.62: Hospira's Performance in APAC Region, 2008 221
Figure 16.63: Hospira's RandD Investment, 2006-2008 221
Figure 16.64: Smith and Nephew's RandD Expenditure, 2006-2008 223
Figure 16.65: Smith and Nephew's Performance by Business Segment, 2008 223
Figure 16.66: Smith and Nephew's Performance by Geographic Market, 2008 224
Figure 16.67: Danaher's Performance by Geography, 2008 224
Figure 16.68: Danaher's RandD Expenditure in its Medical Technologies, 2006-2008
225
Figure 16.69: Medical Technologies Performance: U.S. and Non-U.S., 2006-2008 225
Figure 16.70: Danaher's Performance in Medical Technologies, 2006-2008 226
Figure 16.71: Synthes' Global Performance, 2004-2008 227
Figure 16.72: Synthes' Performance by Geographical Region, 2008 227
Figure 16.73: Beckman Coulter's Global Performance, 2004-2008 228
Figure 16.74: Beckman Coulter's Performance by Geographic Region, 2008 228
Figure 16.75: Olympus' Global Performance, 2004-2008 229
Figure 16.76: Olympus' Performance by Geographic Area, 2008 230
Figure 16.77: Olympus' Performance by Business Segments, 2008 230
Figure 16.78: Fresenius' Group Performance, 2004-2008 231
Figure 16.79: Fresenius' Performance by Geographic Region, 2008 232
Figure 16.80: Fresenius' Performance in Dialysis Products, 2007 and 2008 233
Figure 16.81: Fresenius Kabi's Performance by Geographic Region, 2008 234
Figure 16.82: Alcon Laboratory's Global Performance, 2004-2008 234
Figure 16.83: Alcon Laboratory's Performance by Geographical Segment, 2008 235
Figure 16.84: Alcon Laboratory's RandD Expenditure, 2004-2008 235
Figure 16.85: Alcon's RandD Expenditure by Therapeutic Category, 2008 236
Figure 16.86: Alcon's Global Surgical Market Share, 2004-2008 236
Figure 16.87: Alcon's Global Market Share in Intraocular Lenses, 2004-2008 237
Figure 16.88: Alcon's U.S. Contact Lens Care Solution Market Share, 2008 237
Figure 16.89: Terumo's Performance: General Hospital Products Segment, 2004-2008
238
Figure 16.90: Terumo's Performance: Cardiac and Vascular Products, 2004-2008 239
Figure 16.91: Terumo's Performance: Home Healthcare Products, 2004-2008 240
Figure 16.92: Terumo's Performance by Geographical Region, 2008 241
Figure 16.93: Terumo's RandD Expenditure, 2004-2008 241
Figure 16.94: Bard's Performance in Vascular Products, 2004-2008 242
Figure 16.95: Bard's Performance in Urology Products, 2004-2008 243
Figure 16.96: Bard's Performance in Oncology Products, 2004-2008 244
Figure 16.97: Bard's Performance in Surgical Specialties, 2004-2008 245
Figure 16.98: Capnography Boards Sold by Oridion, 2004-2008 246
Figure 16.99: Oridion's Performance, 2004-2008 247
Figure 16.100: Oridion's Investment in RandD, 2006-2008 248
Figure 16.101: DENTSPLY's Performance by Geographic Segment, 2008 249
Figure 16.102: DENTSPLY's Global Performance, 2004-2008 250
Figure 16.103: Drager's Performance by Region, 2008 251
Figure 16.104: Drager's Business Performance in its Medical Division, 2008 251
Figure 16.105: Drager's Medical Division RandD Expenditure, 2004-2008 252
Figure 16.106: Varian's Performance in its Oncology Systems, 2006-2008 253
Figure 16.107: Performance of Varian's Oncology Systems, 2008 253
Figure 16.108: Varian's Performance in its X-ray Products, 2006-2008 254
Figure 16.109: Performance of Varian's X-ray Products by Geographic Region, 2008
254
Figure 16.110: Varian's RandD Expenditure, 2006-2008 255
Figure 17.1: Global Market for Medical Devices, 2008-2011 257
Figure 17.2: Market Growth for Medical Devices in India, 2008-2015 260
Figure 17.3: Market Growth for Cardiovascular Devices in India, 2008-2015 260
Figure 17.4: Market Growth for Orthopedic Devices in India, 2008-2015 261
Figure 17.5: Interventional Cardiology Market in India, 2008-2012 262
Figure 17.6: Indian Molecular Diagnostics Instruments and Reagent Market, 2008
263
Figure 17.7: Penetration of Cardiology Informatics in India, 2008 264
Figure 17.8: Growth of Market for Medical Devices in Russia, 2008-2013 264
Figure 17.9: Market Growth for Medical Devices in China, 2008-2013 265
Figure 17.10: The Market for Radiology IT in China, 2008 266
Figure 17.11: In Vitro Diagnostic Market in China, 2007-2010 267
Figure 17.12: China's In Vitro Diagnostic Market Value, 2007 267
Figure 17.13: The Top Three Deadly Diseases in China, 2009 269
Figure 17.14: South East Asia's X-ray Market, 2007 271
Figure 17.15: Growth of Ultrasound Market in South East Asia, 2007-2010 272
Figure 17.16: South East Asia's Ultrasound Market Value, 2007 272
Figure 17.17: Percentage of Color Versus Black and White Units Installed in South
East Asia, 2007 273
Figure 17.18: Market Growth for Medical Devices in Malaysia, 2008-2010 273
Figure 17.19: Market Growth for Medical Devices in Indonesia, 2008-2013 274
Figure 17.20: Indonesia's Diagnostic Imaging Market, 2008 275
Figure 17.21: Market Growth for Medical Devices in Singapore, 2008-2012 275
Figure 17.22: Market Growth for Medical Devices in Vietnam, 2009-2014 276
Figure 17.23: Market Growth for Medical Devices in Denmark, 2009-2014 277
Figure 17.24: Market Growth for Medical Devices in the U.K., 2009-2014 277
Figure A1.1: U.S. Medical Device Exports, 2008 278
Figure A1.2: Total U.S. Medical Device Exports, 2007 279
Figure A1.3: Growth of Medical Device Market: France, 2008-2013 279
Figure A1.4: Export of Medical Devices from Turkey by Value, 2004-2008 280
Figure A1.5: Medical Device Market Growth: Romania, 2008-2013 281
Figure A5.1: U.S. Market Growth in Healthcare IT, 2007-2012 295
Figure A5.2: Growth of Global Home Healthcare Equipment Market, 2007-2012 296
Figure A5.3: Growth for Indian Medical Tourism, 2007-2012 296


INDEX OF TABLES

Table 2.1: Technical Information on FreeStyle Lite 32
Table 2.2: Technical Information for Freedom Lite 33
Table 2.3: Technical Information on Precision Xtra 35
Table 2.4: Technical Information for Contour 37
Table 2.5: Technical Information on Contour TS 38
Table 2.6: Technical Information on Breeze2 39
Table 2.7: Technical Information on OneTouch Ultra Mini 41
Table 2.8: Technical Information on OneTouch Ultra2 43
Table 2.9: Technical Information on OneTouch UltraSmart 44
Table 2.10: Technical Information on OneTouch UltraLink 45
Table 2.11: Technical Information on Accu-Chek Compact Plus 47
Table 2.12: Technical Information on Accu-Chek Aviva 49
Table 2.13: Technical Information on True2Go 51
Table 2.14: Technical Information on TRUEresult 52
Table 2.15: Technical Information on TRUEtrack 53
Table 2.16: Technical Information on TRUEread 54
Table 2.17: Technical Information on Sidekick 56
Table 3.1: ResMed's Continuous Positive Airway Products 60
Table 3.2: ResMed's Automatic Positive Airway Products 60
Table 3.3: ResMed's Variable Positive Airway Products 60
Table 3.4: ResMed's Ventilation Products 61
Table 3.5: ResMed's Mask Systems and Diagnostic Products 62
Table 3.6: Sleep Recorders from ResMed 62
Table 4.1: Pulse Oximetry Market Estimate 85
Table 16.1: Fresenius' Medical Care in Asia, 2007 and 2008 232
Table 16.2: APP Pharmaceuticals Statistics, 2008 232
Table 17.1: Leading Global Medical Device Companies, 2008 258
Table A1.1: Turkish Medical Devices Export by Product Groups, 2003-2008 281
Table A2.1: Merger and Acquisition in Medical Device Sector, 2008 283
Table A5.1: Comparison of Cost for Medical Procedures 297

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Global Wound Care Market Outlook

Global Wound Care Market Outlook

  • $ 8 000
  • Industry report
  • October 2014
  • by Frost & Sullivan

Analysis of Wound Care Technologies The global wound care market is at a growth stage. It is driven by the increasingly aging population as well as rising rates of diabetes and obesity. These chronic health ...

Global Continuous Glucose Monitoring System - Glucose Sensors, Geographical Analysis, Artificial Pancreas, Size, Market Overview, Price, Industry Analysis, Market Growth, Market Share, Forecasts 2014 - 2020

Global Continuous Glucose Monitoring System - Glucose Sensors, Geographical Analysis, Artificial Pancreas, Size, Market Overview, Price, Industry Analysis, Market Growth, Market Share, Forecasts 2014 - 2020

  • $ 7 000
  • Industry report
  • November 2014
  • by Occams

Emergence of continuous glucose monitoring systems is a major breakthrough in the glucose monitoring for diabetic patients. Medtronic and Dexcom are the only major players in this industry followed by ...

Intravenous (IV) Therapy and Vein Access: Global Markets

Intravenous (IV) Therapy and Vein Access: Global Markets

  • $ 6 650
  • Industry report
  • November 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for intravenous therapy and vein access was $19.3 billion in 2013. The market reached $20.3 billion in 2014 and is expected to reach about $27.2 billion in 2019, registering ...

World Medical Disposables Market

September 2014 $ 6 400

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.